|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hautmann RE, de Petriconi RC, Pfeiffer C
and Volkmer BG: Radical cystectomy for urothelial carcinoma of the
bladder without neoadjuvant or adjuvant therapy: Long-term results
in 1100 patients. Eur Urol. 61:1039–1047. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Savitz AJ and Meyer DI: 180-kD ribosome
receptor is essential for both ribosome binding and protein
translocation. J Cell Biol. 120:853–863. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsai HY, Yang YF, Wu AT, Yang CJ, Liu YP,
Jan YH, Lee CH, Hsiao YW, Yeh CT, Shen CN, et al: Endoplasmic
reticulum ribosome-binding protein 1 (RRBP1) overexpression is
frequently found in lung cancer patients and alleviates
intracellular stress-induced apoptosis through the enhancement of
GRP78. Oncogene. 32:4921–4931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pan Y, Cao F, Guo A, Chang W, Chen X, Ma
W, Gao X, Guo S, Fu C and Zhu J: Endoplasmic reticulum
ribosome-binding protein 1, RRBP1, promotes progression of
colorectal cancer and predicts an unfavourable prognosis. Br J
Cance. 113:763–772. 2015. View Article : Google Scholar
|
|
6
|
Li T, Wang Q, Hong X, Li H, Yang K, Li J
and Lei B: RRBP1 is highly expressed in prostate cancer and
correlates with prognosis. Cancer Manag Res. 11:3021–3027. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu S, Lin M, Ji H, Ding J, Zhu J, Ma R
and Meng F: RRBP1 overexpression is associated with progression and
prognosis in endometrial endometrioid adenocarcinoma. Diagn Pathol.
14:72019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang L, Wang M, Zhang M, Li X, Zhu Z and
Wang H: Expression and significance of RRBP1 in esophageal
carcinoma. Cancer Manag Res. 10:1243–1249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Legler DF, Allmen EU and Hauser MA: CCR7:
Roles in cancer cell dissemination, migration and metastasis
formation. Int J Biochem Cell Biol. 54:78–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xiong Y, Huang F, Li X, Chen Z, Feng D,
Jiang H, Chen W and Zhang X: CCL21/CCR7 interaction promotes
cellular migration and invasion via modulation of the MEK/ERK1/2
signaling pathway and correlates with lymphatic metastatic spread
and poor prognosis in urinary bladder cancer. Int J Oncol.
51:75–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takanami I: Overexpression of CCR7 mRNA in
nonsmall cell lung cancer: Correlation with lymph node metastasis.
Int J Cancer. 105:186–189. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
An S, Tiruthani K, Wang Y, Xu L, Hu M, Li
J, Song W, Jiang H, Sun J, Liu R and Huang L: Locally trapping the
C-C chemokine receptor Type 7 by gene delivery nanoparticle
inhibits lymphatic metastasis prior to tumor resection. Small.
15:e18051822019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Z, Zhu C, Chen C, Zong Y, Feng H, Liu
D, Feng W, Zhao J and Lu A: CCL19 suppresses angiogenesis through
promoting miR-206 and inhibiting Met/ERK/Elk-1/HIF-1α/VEGF-A
pathway in colorectal cancer. Cell Death Dis. 9:9742018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vasaikar SV, Straub P, Wang J and Zhang B:
LinkedOmics: Analyzing multi-omics data within and across 32 cancer
types. Nucleic Acids Res. 46:D956–D963. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wahafu W, Gai J, Song L, Ping H, Wang M,
Yang F, Niu Y and Xing N: Increased H2S and its
synthases in urothelial cell carcinoma of the bladder, and enhanced
cisplatin-induced apoptosis following H2S inhibition in
EJ cells. Oncol Lett. 15:8484–8490. 2018.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mo M, Zhou M, Wang L, Qi L, Zhou K, Liu
LF, Chen Z and Zu XB: C CL21/CCR7 enhances the proliferation,
migration, and invasion of human bladder cancer T24 cells. PLoS
One. 10:e01195062015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xiong Y, Huang F, Li X, Chen Z, Feng D,
Jiang H, Chen W and Zhang X: CCL21/CCR7 interaction promotes
cellular migration and invasion via modulation of the MEK/ERK1/2
signaling pathway and correlates with lymphatic metastatic spread
and poor prognosis in urinary bladder cancer. Int J Oncol.
51:75–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Wang S, Hu L, Liu F, Zhang Q and
Zhang D: miR-199a-5p suppresses human bladder cancer cell
metastasis by targeting CCR7. BMC Urol. 16:642016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hyde M, Block-Alper L, Felix J, Webster P
and Meyer DI: Induction of secretory pathway components in yeast is
associated with increased stability of their mRNA. J Cell Biol.
156:993–1001. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee AS: Mammalian stress response:
Induction of the glucose-regulated protein family. Curr Opin Cell
Biol. 4:267–273. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui XA, Zhang H and Palazzo AF: p180
promotes the ribosome-independent localization of a subset of mRNA
to the endoplasmic reticulum. PLoS Biol. 10:e10013362012.
View Article : Google Scholar : PubMed/NCBI
|
